What is Akkermansia? The gut mucus bacterium, live and pasteurized, and what trials measured
By the Physician's Choice editorial team.
Published Oct 22, 2026. Last checked Oct 22, 2026. 9 min read. 12 sources.
Published by Physician's Choice, which makes the products discussed on this site.
- 2004Named, from human stool grown on mucin alone.1
- 2019First 3-month human trial: 32 adults finish, on live or pasteurized cells.9
- 2021Europe's food safety agency: the pasteurized form is safe for adults at up to 34 billion cells a day.6
- 2022The EU authorizes the pasteurized form in supplements for adults.7
- 2025The agency judges it safe for teens from 12 at lower amounts; safety in pregnancy is still not established.8
The short answer
Akkermansia muciniphila is a gut bacterium that lives in the mucus lining the intestine and feeds on mucin, the protein in that mucus. Named in 2004, it makes up about 1 to 3% of stool bacteria in most healthy adults, a 2022 review says. It is sold live or pasteurized; Europe's food safety agency judged the pasteurized form safe for adults at up to 34 billion cells a day.
Sources: Derrien et al., 20041; Iwaza et al., 20223; EFSA, 20216.
Akkermansia in five lines
- Mucin
The strain that named the species was grown from human stool on gastric mucin as its only source of carbon and nitrogen; it is Gram-negative, strictly anaerobic and oval.[Derrien et al., 2004]
- Over 90%
It is found in more than 90% of healthy adults tested, at 1 to 3% of stool bacteria, with fewer in older people.[Iwaza et al., 2022]
- 3.4 × 1010
The pasteurized form is safe for adults, not pregnant or breastfeeding women, at up to 3.4 × 1010 cells a day if it holds under 10 live cells per gram, EFSA concluded.[EFSA, 2021]
- Not QPS
EFSA's biological hazards panel judged the species not suitable for its QPS safety status in 2020 and again in 2024, citing safety concerns.[EFSA, 2021 and 2025]
- 32 adults
In the first 3-month trial, in 2019, 32 adults finished on 10 billion cells a day, live or pasteurized, and no adverse events were recorded.[Depommier et al., 2019]
Two lines on Akkermansia, word for word
A. muciniphila is a well-characterised non-toxin producing, avirulent microorganism that has been reported as part of normal gut microbiota.
European Food Safety Authority, Panel on Nutrition, Novel Foods and Food Allergens, 2021, opening its opinion on the pasteurized form
the study was not powered to deliver definitive conclusions
Depommier and colleagues, Nature Medicine, 2019, on their own 3-month trial of 32 adults
Quoted as written; the second line continues by naming the outcomes it applies to. Neither source tested a Physician's Choice product.
What is Akkermansia muciniphila?
A gut bacterium that eats the gut's own mucus. Dutch researchers isolated it in 2004 by growing human stool in a medium with gastric mucin as the only carbon and nitrogen source, and named the new genus and species Akkermansia muciniphila; the type strain is MucT, held as ATCC BAA-835.1 It is Gram-negative, strictly anaerobic, does not move or form spores, and sits in a branch of bacteria called Verrucomicrobia.1
Mucin is the main glycoprotein of the mucus that coats the gut lining, and a 2023 review notes that breaking it down prompts the lining to make new mucus.11 A 2022 review adds that the bacterium tolerates oxygen for up to 72 hours and that low pH strongly slows its growth, which fits its abundance in the far end of the colon.3
Where does Akkermansia live, and how common is it?
In the colon of nearly every adult. A 2008 study that counted it with a DNA probe found it made up more than 1% of all the bacterial cells in stool.2 A 2022 review puts it at 1 to 3% of stool bacteria, present in more than 90% of healthy adults tested and fewer in older people.3 Europe's food safety agency cites a study of 249 people in which it was found in all 54 adults.6
The same study, as the agency reports it, found it in 8 of 50 babies at 1 month and 45 of 50 children at 12 months, with a median of about 100 million cells per gram of stool in adults.6 So a probiotic with Akkermansia adds a species most people already carry; the World Gastroenterology Organisation notes that whether supplementing such bacteria improves health is still an active area of research.5
Why is Akkermansia called a next-generation probiotic?
Because it comes from outside the groups that traditional probiotics are drawn from. A 2017 paper in Nature Microbiology describes next-generation probiotics as gut organisms with less familiar traits whose development is likely to suit a pharmaceutical route more than a food route, a concept that overlaps with live biotherapeutic products, a class developed only for pharmaceutical use.4
The 2023 WGO guideline makes the same split in its glossary: many probiotics are lactic acid bacteria, but some, Akkermansia among them, are not.5 The label "next-generation" says where the organism comes from, not what it has been shown to do, and evidence for any probiotic belongs to the strain tested, as How do probiotics work? explains.
Live or pasteurized Akkermansia: what is the difference?
Whether the cells are alive. Pasteurized Akkermansia is grown without oxygen, then pasteurized, concentrated and freeze-dried, and the EU specification allows under 10 live cells per gram.7 Europe has ruled on that form only: its food safety agency judged it safe for adults in 2021, while its hazards panel judged the species itself not suitable for the QPS list, Europe's presumption-of-safety list for microbes added to food and feed, citing safety concerns.6, 8
| What to compare | Live | Pasteurized |
|---|---|---|
| What it is | Cells that can grow | Cells killed by heat; under 10 live cells per gram in the EU product7 |
| How it is counted | Colony forming units, cells that grow on a plate6 | Total cells, counted by flow cytometry: 25 billion to 2.5 trillion per gram in the EU product7, 6 |
| Standing in Europe | Judged not suitable for QPS status, in 2020 and 2024, citing safety concerns8 | Authorized novel food since 2022, in supplements for adults, up to 3.4 × 1010 cells a day7 |
| Who it is judged safe for | No European safety opinion on a live product found | Adults; teens from 12 at lower amounts in a 2025 opinion; pregnancy and breastfeeding not established6, 8 |
| The 2019 trial | 9 adults finished 3 months at 10 billion cells a day9 | 12 adults finished 3 months at 10 billion cells a day9 |
| EU label rule | No EU authorization found | Must say the supplement is for adults only, not pregnant or breastfeeding women7 |
The table covers European rulings only. The agency set the live-cell limit after weighing about 1,000 live cells a day: "a possible adverse impact on the gut barrier integrity and balance of the microbiota in susceptible people cannot be ruled out based on the available information."6 None of these rulings concerns a Physician's Choice product.
What did human trials of Akkermansia measure?
Mainly safety, in the first small trial. In the 2019 study, 40 adults with a metabolic condition, which this page does not cover, were assigned to placebo, live or pasteurized A. muciniphila at 10 billion bacteria a day for 3 months, and 32 finished: 11 on placebo, 12 on pasteurized and 9 on live cells.9 Its primary endpoints were safety, tolerability and markers tied to the participants' condition.
Both forms were safe and well tolerated, compliance was above 99%, no adverse events were recorded, and the overall structure of the participants' gut bacteria did not change.9 The authors also report changes in blood markers with the pasteurized form, and they call the study exploratory. Five of them are inventors on patent applications for its use, and two co-founded a company that makes it.9
For its 2025 opinion, Europe's food safety agency reviewed newer laboratory, animal and human studies, two of the human ones published in 2024, using live, pasteurized or heat-killed cells of several strains, and wrote that no adverse effects were observed in them.8 Those two trials used other strains in other groups of people, and this page reports none of their outcomes. A 2022 review still calls for more human trials before long-term effects are known.3
Which foods and fibers raise Akkermansia?
Some have, in some trials, and the overall picture is unclear. A 2019 systematic review of 29 diet trials with 1,444 participants, 11 of which measured A. muciniphila, found that certain diets and supplements raised it, among them pomegranate extract, resveratrol, polydextrose, yeast fermentate, sodium butyrate and inulin, while a low-FODMAP diet lowered it.10 The authors call the evidence not clear and ask for more research.
Trials with healthy adults point both ways in that review: polydextrose, a fiber, raised A. muciniphila compared with soluble corn fiber or no added fiber in healthy people, while in a trial that included healthy adults, more resistant starch and wheat bran brought no change.10 Three of the review's nine authors had ties to supplement companies. No food on this list contains Akkermansia; the trials measured the bacterium people already carry.
Does Akkermansia have side effects?
None were recorded in the 2019 trial, and Europe still sets limits. The 2019 trial recorded no adverse events over 3 months in either form.9 Europe's food safety agency could not rule out a possible effect of live cells on the gut barrier in susceptible people, capped live cells in the pasteurized product, and says its safety in pregnancy and breastfeeding has not been established.6, 8
A 2023 review urges caution from another angle: in some gut settings an excess of Akkermansia may not help, the bacterium has the potential to acquire antibiotic resistance genes, and its use "should be evaluated on an individual basis, avoiding risking unexpected effects."11 The same review notes that newer gut bacteria such as this one do not yet have a history of safe use.11
Where Physician's Choice fits
None of the 13 Physician's Choice probiotic Supplement Facts panels read for this page on Oct 22, 2026 lists Akkermansia muciniphila, live or pasteurized; their probiotic lines list lactic acid bacteria, bifidobacteria and Bacillus species.12 No study cited here tested a Physician's Choice product.
Each strain code those labels carry is in the physicianschoice.ai strain register. 100 Billion Probiotic, which this site takes its name from, appears by name only until its label is confirmed.
Talk to a doctor if
- One of these applies to you. Physician's Choice's own line: "If you are pregnant or breastfeeding, are seriously ill, or have a weakened immune system, consult your healthcare provider before taking a probiotic or any other dietary supplement."
- The supplement is for someone under 18. The EU authorization covers adults, and Europe's food safety agency set lower daily amounts for teens from 12 in 2025.
- You hope it will help a health condition. The first human trial is one small 3-month study whose authors call it exploratory, and this page reports no outcome from the later trials.
- A reaction worries you. Physician's Choice: "If you experience an adverse event, stop using the product and contact your healthcare provider immediately. Please also notify us at support@physicianschoice.com or 1-877-395-2707."
Akkermansia, in sum
Akkermansia muciniphila is a common gut bacterium that lives on the intestine's mucus, sold as a next-generation probiotic in live and pasteurized forms. Europe has judged only the pasteurized form safe, for adults at up to 34 billion cells a day, the trial behind Europe's ruling is one small study, and diet trials that tried to raise it give mixed results.
Where these numbers come from
- September 12 to October 12, 2026
- Public Reddit posts we read: 1,145, from 250 communities; 62 were about probiotics, and none mentioned Akkermansia.
- The question
- "What is Akkermansia?", with what people ask next: probiotics with Akkermansia, foods that raise it, and its side effects.
- Oct 22, 2026
- Read the 2004 paper that named the species, a 2008 counting study, three reviews, a 2017 paper on next-generation probiotics, the 2023 WGO guideline, two European food safety opinions and the EU regulation that authorizes the pasteurized form, the 2019 human trial and 13 Physician's Choice probiotic labels. Each quote was checked against its source text.
- Left out
- Animal results, studies in people with named diseases, the companies that sell Akkermansia, and any outcome for a Physician's Choice product.
- Oct 28, 2026
- Added the new answer on probiotic strains to the list of other answers.
- Nov 9, 2026
- Added the new answer on Lactobacillus rhamnosus to the list of other answers.
- Next
- Each recheck adds a dated line here.
Asked about Akkermansia
What does Akkermansia do?
In the gut, it breaks down mucin, the protein of the mucus that lines the intestine, and lives on it; the strain that named the species was grown on mucin as its only source of carbon and nitrogen. What a supplement does in people is still being measured: the first 3-month trial had 32 adults finish.
What foods increase Akkermansia?
No food is a proven source. A 2019 review of 29 diet trials found pomegranate extract, resveratrol, polydextrose, yeast fermentate, sodium butyrate and inulin raised it in some trials, and a low-FODMAP diet lowered it. The authors call the evidence not clear, and one trial that included healthy adults saw no change with resistant starch and wheat bran.
Is Akkermansia a probiotic?
It is sold as one, and researchers call it a next-generation probiotic, a term for gut microbes outside the traditional probiotic groups. It is not on Europe's QPS safety list: the food safety agency's hazards panel judged the species not suitable, citing safety concerns. The pasteurized form is authorized in the EU for adults.
What are the side effects of Akkermansia?
In the 2019 trial, 32 adults finished 3 months on 10 billion cells a day, live or pasteurized, with no adverse events recorded. Europe's food safety agency said a possible adverse effect of live cells on the gut barrier in susceptible people cannot be ruled out, and its safety in pregnancy and breastfeeding has not been established.
Is pasteurized Akkermansia alive?
No. Pasteurization kills the cells, and the EU specification allows under 10 live cells per gram, the limit of detection. That is why it is counted as total cells rather than as colony forming units. Europe's food safety agency judged it safe for adults at up to 34 billion cells a day.
Other answers on this site
- Lactobacillus rhamnosus: what it is, the GG and GR-1 strains, and what trials measuredPublished Nov 9, 2026. The species and its new name, the GG and GR-1 strains, and their trials.
- Probiotic strains: what a strain is, and what the letters and numbers after the name meanPublished Oct 28, 2026. Genus, species and strain, and what the code after the name means.
- What is Saccharomyces boulardii? The probiotic yeast, its strain code and safetyPublished Oct 22, 2026. The probiotic that is a yeast, and why antibiotics leave it alone.
- What are spore-based probiotics? Bacillus on the label, new names and safetyPublished Oct 18, 2026. Spores, Bacillus species and their new genus names.
- What is Bifidobacterium? The species on probiotic labels, and what was studiedPublished Oct 16, 2026. The genus, its label species and single-strain studies.
- How do probiotics work? What happens after you swallow onePublished Oct 16, 2026. Mechanisms, stomach acid, colonizing the gut and how long strains stay.
- What is the strongest probiotic? What "strong" can mean on a labelPublished Oct 15, 2026. CFU, strain counts, survival to the date and evidence, side by side.
- What does CFU mean on a probiotic label?Published Oct 9, 2026. The colony forming unit, and when the count applies.
- How many CFU should a daily probiotic have? Doses used in studiesPublished Oct 6, 2026. NIH ranges and the doses used in studies, strain by strain.
- Is a 100 billion CFU probiotic better than a 60 billion CFU probiotic?Published Oct 8, 2026. What NIH, ISAPP and WGO say about higher counts.
- Can you take probiotics with antibiotics? Timing, spacing and what to askPublished Oct 10, 2026. How many hours apart, and what to ask a pharmacist.
- Can you take too many probiotics? Doubling up, symptoms and limitsPublished Oct 10, 2026. Upper limits, mild symptoms and taking two products.
Sources
- Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacteriumInternational Journal of Systematic and Evolutionary Microbiology, 2004. The paper that named the species.
- Derrien M, Collado MC, Ben-Amor K, Salminen S, de Vos WM. The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tractApplied and Environmental Microbiology, 2008. How common it is in stool.
- Iwaza R, Wasfy RM, Dubourg G, Raoult D, Lagier JC. Akkermansia muciniphila: the state of the art, 18 years after its first discoveryFrontiers in Gastroenterology, 2022. Abundance, oxygen and pH, and the need for more human trials. The authors declare no commercial or financial relationships.
- O'Toole PW, Marchesi JR, Hill C. Next-generation probiotics: the spectrum from probiotics to live biotherapeuticsNature Microbiology, 2017. What "next-generation probiotic" means.
- World Gastroenterology Organisation Global Guideline: Probiotics and prebiotics2023. Akkermansia outside the lactic acid bacteria, and the open research question.
- EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Safety of pasteurised Akkermansia muciniphila as a novel food pursuant to Regulation (EU) 2015/2283EFSA Journal, 2021 (adopted Jul 7, 2021). The safe amount, the live-cell limit and how often it is found.
- Commission Implementing Regulation (EU) 2022/168 authorising the placing on the market of pasteurised Akkermansia muciniphila as a novel foodRegulation of Feb 8, 2022, Official Journal of the European Union L 28, Feb 9, 2022. Authorization, limits, label rule and specification.
- EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Safety of an extension of use of pasteurised Akkermansia muciniphila as a novel food pursuant to Regulation (EU) 2015/2283EFSA Journal, 2025. Teens, pregnancy, newer studies and the QPS ruling.
- Depommier C, Everard A, Druart C, et al. Supplementation with Akkermansia muciniphila in [...] human volunteers: a proof-of-concept exploratory studyNature Medicine, 2019. The 3-month trial. Five authors are inventors on patent applications for its use, and two co-founded a company that makes it.
- Verhoog S, Taneri PE, Roa Díaz ZM, et al. Dietary factors and modulation of bacteria strains of Akkermansia muciniphila and Faecalibacterium prausnitzii: a systematic reviewNutrients, 2019. What diet trials found. One author works for a supplement company and two reported grants or fees from supplement companies.
- Chiantera V, Laganà AS, Basciani S, Nordio M, Bizzarri M. A critical perspective on the supplementation of Akkermansia muciniphila: benefits and harmsLife, 2023. Mucin, resistance genes and caution. The authors declare no conflict of interest.
- Physician's Choice Supplement Facts panels for 13 probiotic productsLabel images on the product pages at physicianschoice.com, read Oct 22, 2026.